Answers are grounded in this paper and cite their sources.
Photoaffinity labeling is an integral technique in drug development for identifying the biological targets of drug-like molecules. An essential step in this process is the design and synthesis of photocrosslinking probe molecules that contain the key biologically active warhead of the parent molecule, a photo-activatable functional group, and a biorthogonal handle. These components collectively allow for the covalent linkage of the drug to its target and subsequent isolation of the drug-protein conjugate. Current strategies to synthesize probes from their parent molecules rely on previously installed functional groups or a redesigned synthesis. Here, we report the late-stage synthesis of photoaffinity labeling probes using photochemical Minisci chemistry, where we can convert a variety of medicinally relevant aromatic N-heterocycles to their corresponding photo-crosslinking probes in a single step. Furthermore, employing our method, we synthesized photoaffinity labeling probe analogs of pioglitazone, a known peroxisome proliferator-activated receptor gamma (PPARγ) agonist. We performed photo-crosslinking and pull-down experiments to validate the target of pioglitazone, showcasing the utility of this method.
No takes yet. Share an insight, caveat, or question.
Duncan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: